Susan Redican

Susan Redican has extensive experience in the pharmaceutical and biotechnology industry. Susan is currently the Vice President, Head of Clinical Operations at Spero Therapeutics, a role they started in February 2023. Prior to this, they worked as an Independent Consultant, serving as a Clinical Operations Consultant from June 2022 to February 2023.

From 2017 to 2022, Susan worked at Solid Biosciences, first as a Senior Director, Clinical Operations from August 2017 to January 2020, and then as the VP, Clinical Operations from January 2020 to June 2022.

Before Solid Biosciences, they worked at TetraPhase Pharmaceuticals as the Director of Clinical Research from May 2012 to August 2017. Susan also gained experience at Novartis Oncology Translational Medicine, where they were a Clinical Trial Head (Consultant - Gemini Staffing, LLC) from November 2011 to June 2012.

Susan'scareer started at Tolerx, Inc. in 2005, where they worked as an Associate Director of Clinical Study Management from June 2005 to March 2011.

Susan Redican holds a Master of Science degree in Nutrition from Tufts University. No specific start or end year for their education at Tufts University has been provided.